← Browse by Condition
Medical Condition
vaccine response
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 1, Phase 4
ClinicalMetric tracks all active clinical trials for vaccine response sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 1 1
Phase 4 1
Top Sponsors
1 trial
1 trial
1 trial
NCT06821100 Phase 1
Recruiting
Thymalfasin (Thymosin Alpha 1; Ta1) as an Enhancer of Vaccine Response Among Older Adults Receiving Booster Doses of COVID-19 Vaccine
Enrollment
75 pts
Location
United States
Sponsor
The Methodist Hospital Researc...
NCT06635525
Recruiting
Impact Of Kidney Failure On The Regulation Of Humoral Response To Vaccination
Enrollment
146 pts
Location
Italy
Sponsor
Fondazione IRCCS Ca' Granda, O...
NCT05518500 Phase 4
Recruiting
A Deep Longitudinal Analysis of Next Generation Influenza Vaccines in Older Adults
Enrollment
75 pts
Location
United States
Sponsor
The Jackson Laboratory
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology